Overall, the molecular basis of compromised intestinal drug efflux during obesity indicated BCRP interactions with Jak3 was essential for BCRP tyrosine phosphorylation (BCRP-P) that facilitated BCRP-P interactions with β-catenin (Figure 8). The gene discussed is JAK3; the disease is obesity disorder.